Application of ZNRF3/RNF43 in preparation of medicine for regulating energy metabolism

An energy metabolism and drug technology, applied in metabolic diseases, drug combinations, pharmaceutical formulations, etc., can solve problems such as lack of energy metabolism, and achieve the effects of improving liver insulin resistance, reducing liver lipid deposition, and increasing glucose sensitivity
CN111920951AActive Publication Date: 2020-11-13RUIJIN HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE +1
1 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
RUIJIN HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE
Publication Date
2020-11-13

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to application of ZNRF3 / RNF43 in preparation of a medicine for regulating energy metabolism. It proves that the ZNRF3 / RNF43 double knockout can reduce the blood sugar content andserum insulin level, increase the sensitivity of the body to glucose and down-regulate the expression of glucose allogeneic related genes; meanwhile, liver lipid deposition is reduced, lipid synthesis and expression of inflammation-related genes are reduced, it is shown that the ZNRF3 / RNF43 double knockout can improve liver insulin resistance possibly through the ways of influencing glycoxenesis,lipid synthesis and the like, and then a theoretical basis is provided for preparing energy metabolism regulating medicine.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the field of drugs for type 2 diabetes, and in particular relates to the application of ZNRF3 / RNF43 in the preparation of drugs for regulating energy metabolism. Background technique

[0002] Ring finger proteins ZNRF3 (zinc ring finger protein 3) and RNF43 (ring finger protein 43) are two homologous single-transmembrane E3 ubiquitin ligases, both of which belong to the Goliath protein family and are conserved genes in many organisms , is stably expressed in a variety of vertebrates. ZNRF3 is located on human chromosome 22, and RNF43 is located on chromosome 17. The two structures are similar and have certain homology. They are composed of four parts, signal peptide (signal peptide, SP), extracellular domain (protease -associated domain, PA region), transmembrane domain (transmembrane domain) and intracellular ubiquitination functional domain - ring domain (RING domain), ZNRF3 and RNF43 are functional homologues of each other....

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More